Table 10CDR Analyses — Event Treatment Costs: Hospitalization and Emergency Room Visits

Mfr. Base-
Case Hosp.
Values
(EM | CM)		Mfr. Base-
Case ER
Values
(EM | CM)		Mfr. Base-Case
ICUR		Revised Hosp.
and ER Values		CDR Reanalysis
ICUR
Full population0.030.090.100.41$28,9400.00$34,939
Subpopulation$25,470$31,740

CDR = CADTH Common Drug Review; CM = chronic migraine (defined as ≥ 15 HDPM); EM = episodic migraine (defined as < 15 HDPM); ER = emergency room; Hosp = hospitalization; ICUR = incremental cost-utility ratio; Mfr = manufacturer.

From: 3, RESULTS

Cover of OnabotulinumtoxinA for Injection (Botox)
OnabotulinumtoxinA for Injection (Botox): For the Prophylaxis of Headaches in Adults With Chronic Migraine (≥ 15 Days per Month With Headache Lasting 4 Hours a Day or Longer) [Internet].
Copyright © CADTH 2015.

You are permitted to make copies of this document for non-commercial purposes, provided it is not modified when reproduced and appropriate credit is given to CADTH. You may not otherwise copy, modify, translate, post on a website, store electronically, republish, or redistribute any material from this document in any form or by any means without the prior written permission of CADTH.

Please contact CADTH’s Vice-President of Corporate Services at ac.htdac@secivresetaroproc with any inquiries about this notice or other legal matters relating to CADTH’s services.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.